4.40
+0.06(+1.38%)
Currency In USD
| Previous Close | 4.34 |
| Open | 4.32 |
| Day High | 4.45 |
| Day Low | 4.23 |
| 52-Week High | 8.54 |
| 52-Week Low | 1.99 |
| Volume | 31,191 |
| Average Volume | 222,284 |
| Market Cap | 167.43M |
| PE | -5 |
| EPS | -0.88 |
| Moving Average 50 Days | 5.61 |
| Moving Average 200 Days | 3.84 |
| Change | 0.06 |
If you invested $1000 in Genelux Corporation (GNLX) since IPO date, it would be worth $715.45 as of December 25, 2025 at a share price of $4.4. Whereas If you bought $1000 worth of Genelux Corporation (GNLX) shares 1 year ago, it would be worth $1,788.62 as of December 25, 2025 at a share price of $4.4.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 26, 2025 1:00 PM GMT
WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief F
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 8:01 PM GMT
WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief F
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
GlobeNewswire Inc.
Jul 07, 2025 11:00 AM GMT
WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance